Drugs / Hp129Xenon
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1/2 | NCT03603899 | Sep 2020 → May 2024 | transplant-related bronchiolitis obliterans | Children's Hospital Medical Center, Cincinnati | Completed | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Hp129Xenon | “Participants will inhale up to 4 doses of Hp129Xenon; each dose will be no more than 1 liter.” NCT03603899 ↗ |
| Modality | Diagnostic / imaging agent | “to provide better pictures of the lungs during MRI” NCT03603899 ↗ |
| Route | Inhaled | “then inhaled into the lungs” NCT03603899 ↗ |